PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹369 Cr | ₹656 Cr | ₹368 Cr | ₹407 Cr | ₹367 Cr |
What is the latest Contingent Liabilities ratio of PANACEA BIOTEC ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹369 Cr |
Mar2023 | ₹656 Cr |
Mar2022 | ₹368 Cr |
Mar2021 | ₹407 Cr |
Mar2020 | ₹367 Cr |
How is Contingent Liabilities of PANACEA BIOTEC Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹369 Cr | -43.67 | |
Mar2023 | ₹656 Cr | 78.11 | |
Mar2022 | ₹368 Cr | -9.54 | |
Mar2021 | ₹407 Cr | 10.92 | |
Mar2020 | ₹367 Cr | - |
Compare Contingent Liabilities of peers of PANACEA BIOTEC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PANACEA BIOTEC | ₹1,991.6 Cr | -10.5% | -25.9% | 92% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,744.0 Cr | -4.2% | -7.7% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,209.0 Cr | -0.6% | -5.6% | 57.5% | Stock Analytics | |
CIPLA | ₹117,762.0 Cr | 3.3% | -4.8% | 6.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,705.3 Cr | -2.4% | -12.8% | 1.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,929.3 Cr | -0.3% | -2.1% | 24.5% | Stock Analytics |
PANACEA BIOTEC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PANACEA BIOTEC | -10.5% |
-25.9% |
92% |
SENSEX | 0.3% |
-1.8% |
8.6% |
You may also like the below Video Courses